| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
130,701 |
117,315 |
$48.52M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
99,901 |
89,103 |
$45.31M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
57,361 |
49,035 |
$21.66M |
| G0378 |
Hospital observation service, per hour |
30,276 |
21,333 |
$14.72M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
25,089 |
2,845 |
$7.90M |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
21,220 |
19,607 |
$6.32M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
30,424 |
28,483 |
$5.95M |
| S9480 |
Intensive outpatient psychiatric services, per diem |
6,409 |
5,761 |
$5.27M |
| 59025 |
Fetal non-stress test |
7,043 |
3,204 |
$3.53M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12,752 |
12,213 |
$2.97M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
14,238 |
11,865 |
$2.80M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
5,616 |
5,548 |
$2.11M |
| 70450 |
Computed tomography, head or brain; without contrast material |
19,752 |
18,447 |
$2.01M |
| A0425 |
Ground mileage, per statute mile |
44,023 |
36,925 |
$1.98M |
| A0434 |
Specialty care transport (sct) |
3,686 |
3,485 |
$1.75M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
7,890 |
7,207 |
$1.44M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,935 |
2,141 |
$1.33M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
23,056 |
19,318 |
$1.25M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
680 |
653 |
$1.22M |
| OP250 |
|
392,842 |
153,924 |
$1.20M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,449 |
2,376 |
$1.15M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
410 |
410 |
$1.15M |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
7,905 |
7,062 |
$1.03M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
5,622 |
5,387 |
$1.02M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
7,283 |
7,234 |
$920K |
| 76801 |
|
9,646 |
8,394 |
$907K |
| OP370 |
|
6,543 |
6,089 |
$830K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
50,270 |
43,688 |
$784K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
1,501 |
157 |
$749K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,742 |
3,607 |
$708K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
7,198 |
6,984 |
$674K |
| 71046 |
Radiologic examination, chest; 2 views |
36,475 |
34,793 |
$660K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
7,174 |
6,911 |
$655K |
| OP710 |
|
8,056 |
6,575 |
$642K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
6,033 |
5,664 |
$637K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
787 |
759 |
$607K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
22,520 |
19,966 |
$603K |
| 76830 |
Ultrasound, transvaginal |
6,465 |
6,295 |
$566K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
5,959 |
5,819 |
$555K |
| 76813 |
|
3,836 |
3,779 |
$554K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
6,697 |
4,542 |
$493K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
103,355 |
87,353 |
$488K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
37,232 |
33,256 |
$475K |
| 93017 |
|
1,649 |
1,593 |
$469K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
16,743 |
15,603 |
$465K |
| 93970 |
|
3,532 |
3,396 |
$465K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,406 |
1,337 |
$435K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,305 |
2,195 |
$429K |
| 93971 |
|
3,524 |
3,377 |
$422K |
| J9271 |
Injection, pembrolizumab, 1 mg |
38 |
24 |
$402K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
110,592 |
88,400 |
$381K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
6,684 |
6,634 |
$377K |
| 70486 |
|
2,325 |
2,248 |
$366K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,107 |
3,435 |
$353K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
20,108 |
18,764 |
$340K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,139 |
1,111 |
$311K |
| OP272 |
|
8,268 |
4,857 |
$299K |
| 71045 |
Radiologic examination, chest; single view |
21,634 |
19,889 |
$292K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
1,331 |
1,267 |
$282K |
| 71250 |
|
1,596 |
1,537 |
$264K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,628 |
7,329 |
$263K |
| 76770 |
|
2,463 |
2,362 |
$261K |
| 77066 |
Tomosynthesis, mammo |
1,301 |
1,286 |
$235K |
| 80053 |
Comprehensive metabolic panel |
21,459 |
16,928 |
$234K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,117 |
14,751 |
$223K |
| 76642 |
|
2,467 |
2,284 |
$222K |
| 97597 |
|
974 |
540 |
$218K |
| 93976 |
|
1,229 |
1,184 |
$213K |
| 77336 |
|
1,891 |
765 |
$210K |
| A0433 |
Advanced life support, level 2 (als 2) |
565 |
554 |
$206K |
| 77412 |
|
2,680 |
255 |
$202K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
448 |
439 |
$200K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
150 |
143 |
$197K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
665 |
77 |
$184K |
| G0177 |
Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) |
2,650 |
306 |
$182K |
| 93458 |
|
124 |
111 |
$178K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,133 |
1,125 |
$178K |
| 72100 |
|
5,283 |
5,165 |
$173K |
| 96417 |
|
605 |
355 |
$161K |
| 73562 |
|
6,619 |
6,402 |
$154K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,512 |
2,403 |
$150K |
| A0998 |
Ambulance response and treatment, no transport |
777 |
752 |
$146K |
| 77065 |
Tomosynthesis, mammo |
1,184 |
1,145 |
$141K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
7,433 |
6,036 |
$140K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
11,125 |
10,350 |
$132K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
2,380 |
2,320 |
$131K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,624 |
6,876 |
$130K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,454 |
1,301 |
$130K |
| 87428 |
|
13,277 |
12,752 |
$128K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,286 |
8,150 |
$125K |
| 73630 |
|
6,227 |
6,019 |
$125K |
| 96415 |
|
327 |
209 |
$124K |
| 90791 |
Psychiatric diagnostic evaluation |
4,349 |
3,692 |
$120K |
| 76536 |
|
1,051 |
1,036 |
$119K |
| J2406 |
Injection, oritavancin (kimyrsa), 10 mg |
120 |
108 |
$117K |
| 73030 |
|
4,952 |
4,768 |
$116K |
| OP270 |
|
8,963 |
6,754 |
$115K |
| 80320 |
|
7,411 |
6,452 |
$114K |
| 36415 |
Collection of venous blood by venipuncture |
40,165 |
30,863 |
$111K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,212 |
675 |
$109K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13,517 |
10,313 |
$108K |
| 73130 |
|
5,117 |
4,928 |
$107K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12,392 |
9,050 |
$102K |
| 73610 |
|
5,479 |
5,264 |
$100K |
| 76818 |
|
660 |
477 |
$98K |
| 72131 |
|
693 |
678 |
$98K |
| 77080 |
|
1,015 |
1,004 |
$94K |
| 84484 |
|
30,945 |
24,958 |
$94K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,816 |
3,626 |
$92K |
| OP379 |
|
2,045 |
1,808 |
$90K |
| 76376 |
|
3,443 |
3,299 |
$89K |
| 94060 |
|
265 |
260 |
$84K |
| 76857 |
|
2,291 |
2,196 |
$84K |
| 76870 |
|
1,231 |
1,185 |
$82K |
| 85027 |
|
33,290 |
27,056 |
$80K |
| 74022 |
|
4,137 |
3,996 |
$79K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,498 |
6,016 |
$79K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
1,551 |
1,477 |
$76K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,879 |
7,662 |
$75K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,431 |
6,880 |
$75K |
| 70491 |
|
434 |
418 |
$73K |
| J1815 |
Injection, insulin, per 5 units |
5,235 |
3,290 |
$71K |
| 82948 |
|
42,395 |
30,993 |
$71K |
| 10060 |
|
1,645 |
1,540 |
$70K |
| 58558 |
|
26 |
25 |
$68K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,158 |
1,079 |
$66K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,879 |
7,661 |
$66K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,021 |
569 |
$65K |
| 85610 |
|
23,008 |
17,922 |
$64K |
| 84703 |
|
56,008 |
50,963 |
$64K |
| 73110 |
|
2,985 |
2,905 |
$62K |
| 80076 |
|
29,033 |
26,271 |
$60K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
541 |
541 |
$57K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
840 |
683 |
$57K |
| 74018 |
|
3,051 |
2,823 |
$56K |
| 82077 |
|
11,311 |
9,672 |
$53K |
| 71271 |
|
558 |
550 |
$53K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
47,581 |
40,559 |
$53K |
| 76820 |
|
682 |
499 |
$52K |
| 72040 |
|
1,958 |
1,884 |
$52K |
| 77334 |
|
99 |
57 |
$52K |
| 93880 |
|
257 |
245 |
$51K |
| 12001 |
|
1,276 |
1,201 |
$50K |
| G0410 |
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
1,244 |
201 |
$48K |
| 90715 |
|
5,147 |
5,043 |
$48K |
| 99215 |
Prolong outpt/office vis |
3,285 |
2,671 |
$48K |
| 93460 |
|
30 |
24 |
$46K |
| 81001 |
|
53,362 |
49,382 |
$43K |
| 73502 |
|
2,407 |
2,325 |
$42K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
30,826 |
28,132 |
$40K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
535 |
504 |
$39K |
| J2785 |
Injection, regadenoson, 0.1 mg |
270 |
258 |
$39K |
| 94644 |
|
2,505 |
2,253 |
$38K |
| 73080 |
|
1,856 |
1,801 |
$37K |
| C1769 |
Guide wire |
1,790 |
1,554 |
$36K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,092 |
2,065 |
$35K |
| 12011 |
|
924 |
844 |
$34K |
| J2704 |
Injection, propofol, 10 mg |
8,231 |
7,579 |
$33K |
| 83690 |
|
25,992 |
23,739 |
$32K |
| J1644 |
Injection, heparin sodium, per 1000 units |
9,849 |
5,223 |
$32K |
| 71101 |
|
1,609 |
1,564 |
$31K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
37 |
37 |
$31K |
| 76775 |
|
379 |
371 |
$31K |
| 80061 |
Lipid panel |
4,589 |
4,466 |
$30K |
| 83735 |
|
17,614 |
13,828 |
$30K |
| 96376 |
|
2,759 |
2,458 |
$28K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
419 |
327 |
$28K |
| 85007 |
|
10,007 |
8,758 |
$27K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15,924 |
14,150 |
$26K |
| 73590 |
|
1,477 |
1,413 |
$25K |
| 87631 |
|
1,008 |
993 |
$25K |
| 87070 |
|
9,354 |
9,088 |
$25K |
| 83880 |
|
4,654 |
4,162 |
$24K |
| 86703 |
|
1,356 |
1,353 |
$24K |
| 70498 |
|
183 |
177 |
$24K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
27,276 |
24,187 |
$24K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
32 |
27 |
$24K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,617 |
1,719 |
$23K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,598 |
7,846 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,227 |
6,821 |
$23K |
| 70496 |
|
142 |
139 |
$23K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
4,552 |
4,253 |
$22K |
| 84702 |
|
5,609 |
4,777 |
$22K |
| 85730 |
|
12,861 |
11,819 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,075 |
1,905 |
$21K |
| 95819 |
|
89 |
85 |
$21K |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
481 |
120 |
$20K |
| 94729 |
|
255 |
250 |
$20K |
| 83605 |
|
6,050 |
5,392 |
$20K |
| 73140 |
|
1,722 |
1,684 |
$20K |
| 73090 |
|
1,102 |
1,072 |
$19K |
| 86900 |
|
6,459 |
6,012 |
$19K |
| 87186 |
|
3,484 |
3,325 |
$19K |
| 86885 |
|
5,519 |
5,142 |
$19K |
| 80047 |
|
6,725 |
6,317 |
$19K |
| 29515 |
|
1,162 |
1,093 |
$18K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
1,090 |
1,057 |
$18K |
| 49083 |
|
81 |
40 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,058 |
7,889 |
$18K |
| J0897 |
Injection, denosumab, 1 mg |
25 |
25 |
$18K |
| 29125 |
|
1,435 |
1,328 |
$18K |
| J0185 |
Injection, aprepitant, 1 mg |
137 |
84 |
$17K |
| 77290 |
|
70 |
54 |
$17K |
| 82805 |
|
4,259 |
3,883 |
$17K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
23 |
14 |
$16K |
| 12002 |
|
478 |
450 |
$16K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
7,315 |
6,901 |
$16K |
| 97161 |
|
1,536 |
1,402 |
$16K |
| 72052 |
|
179 |
176 |
$16K |
| J2060 |
Injection, lorazepam, 2 mg |
6,758 |
5,818 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,123 |
1,086 |
$15K |
| 82728 |
|
1,876 |
1,736 |
$15K |
| 86787 |
|
648 |
647 |
$15K |
| 81003 |
|
15,319 |
14,607 |
$15K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,736 |
5,488 |
$15K |
| 87077 |
|
3,711 |
3,539 |
$15K |
| 87088 |
|
8,992 |
8,557 |
$15K |
| 77300 |
|
45 |
26 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,300 |
2,119 |
$14K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
9,708 |
8,218 |
$14K |
| 94727 |
|
227 |
222 |
$13K |
| 84100 |
|
7,979 |
6,377 |
$13K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,156 |
1,294 |
$13K |
| 82550 |
|
6,420 |
5,164 |
$13K |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,278 |
2,817 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
313 |
223 |
$13K |
| 99205 |
Prolong outpt/office vis |
679 |
613 |
$12K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
5,721 |
3,121 |
$12K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,851 |
5,772 |
$12K |
| J1953 |
Injection, levetiracetam, 10 mg |
1,299 |
980 |
$11K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,445 |
2,813 |
$11K |
| 86901 |
|
6,467 |
6,024 |
$11K |
| 87040 |
|
3,159 |
2,928 |
$11K |
| 86803 |
|
767 |
762 |
$11K |
| 72070 |
|
376 |
366 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
815 |
802 |
$11K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
579 |
68 |
$11K |
| 80329 |
|
408 |
391 |
$10K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
10,037 |
8,908 |
$10K |
| 84145 |
|
2,958 |
2,252 |
$10K |
| 96523 |
|
108 |
101 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
758 |
727 |
$10K |
| 88304 |
|
853 |
798 |
$10K |
| 82607 |
|
1,626 |
1,514 |
$10K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
2,887 |
2,542 |
$10K |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
1,430 |
1,190 |
$10K |
| 95816 |
|
15 |
15 |
$10K |
| 86710 |
|
4,404 |
4,342 |
$10K |
| 76000 |
|
472 |
433 |
$9K |
| 85380 |
|
6,714 |
6,490 |
$9K |
| 93571 |
|
13 |
12 |
$9K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,854 |
3,526 |
$9K |
| 74174 |
|
58 |
55 |
$9K |
| 70360 |
|
457 |
449 |
$9K |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
181 |
146 |
$9K |
| 74246 |
|
57 |
55 |
$8K |
| J1756 |
Injection, iron sucrose, 1 mg |
389 |
118 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
571 |
565 |
$8K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,282 |
720 |
$8K |
| 96411 |
|
45 |
24 |
$8K |
| 74247 |
|
42 |
42 |
$8K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
147 |
141 |
$8K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
70 |
66 |
$7K |
| 72141 |
|
26 |
24 |
$7K |
| 31505 |
|
261 |
153 |
$7K |
| 73560 |
|
177 |
160 |
$7K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,181 |
1,081 |
$7K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,847 |
2,125 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
900 |
862 |
$7K |
| 83540 |
|
1,911 |
1,756 |
$7K |
| J1630 |
Injection, haloperidol, up to 5 mg |
3,092 |
2,684 |
$6K |
| 73564 |
|
264 |
253 |
$6K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
115 |
113 |
$6K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
358 |
303 |
$6K |
| 74183 |
|
16 |
16 |
$6K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,046 |
1,902 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,877 |
6,608 |
$6K |
| 87205 |
|
1,912 |
1,815 |
$6K |
| 74019 |
|
351 |
345 |
$6K |
| 83519 |
|
1,342 |
1,279 |
$6K |
| 80164 |
|
426 |
378 |
$6K |
| 96367 |
|
379 |
300 |
$5K |
| 87641 |
|
286 |
254 |
$5K |
| OP279 |
|
1,897 |
1,881 |
$5K |
| 82746 |
|
920 |
864 |
$5K |
| 78582 |
|
78 |
78 |
$5K |
| 36430 |
|
369 |
265 |
$5K |
| 97162 |
|
437 |
395 |
$5K |
| 93325 |
|
12 |
12 |
$5K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
7,523 |
6,850 |
$4K |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,933 |
1,158 |
$4K |
| 99201 |
|
396 |
396 |
$4K |
| 97116 |
|
1,313 |
965 |
$4K |
| 58300 |
|
147 |
137 |
$4K |
| 83615 |
|
927 |
806 |
$4K |
| 86140 |
|
4,223 |
4,005 |
$4K |
| 99152 |
|
403 |
332 |
$4K |
| 82553 |
|
1,229 |
969 |
$4K |
| 83020 |
|
633 |
633 |
$4K |
| 78580 |
|
64 |
60 |
$3K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
102 |
86 |
$3K |
| 84550 |
|
617 |
588 |
$3K |
| 84439 |
|
1,031 |
994 |
$3K |
| OP278 |
|
44 |
39 |
$3K |
| 72110 |
|
43 |
43 |
$3K |
| 84144 |
|
168 |
167 |
$3K |
| 88341 |
|
74 |
65 |
$3K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
173 |
155 |
$3K |
| 88307 |
|
174 |
159 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,884 |
2,336 |
$3K |
| OP258 |
|
1,676 |
1,153 |
$3K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
473 |
456 |
$3K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,089 |
914 |
$3K |
| 88342 |
|
497 |
451 |
$3K |
| 82248 |
|
527 |
490 |
$3K |
| S9484 |
Crisis intervention mental health services, per hour |
160 |
89 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,185 |
2,528 |
$3K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
101 |
88 |
$2K |
| 73552 |
|
197 |
194 |
$2K |
| 11981 |
|
26 |
25 |
$2K |
| 90375 |
|
12 |
12 |
$2K |
| 72128 |
|
27 |
25 |
$2K |
| 84132 |
|
1,650 |
1,489 |
$2K |
| 86706 |
|
232 |
229 |
$2K |
| 87340 |
|
1,069 |
1,062 |
$2K |
| 82330 |
|
772 |
713 |
$2K |
| 85045 |
|
912 |
739 |
$2K |
| 72170 |
|
170 |
156 |
$2K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
87 |
83 |
$2K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
46 |
42 |
$2K |
| 73060 |
|
90 |
88 |
$2K |
| 86762 |
|
726 |
726 |
$2K |
| 84156 |
|
977 |
799 |
$2K |
| A9540 |
Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries |
151 |
140 |
$2K |
| 88312 |
|
594 |
569 |
$2K |
| 72072 |
|
145 |
135 |
$1K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
512 |
385 |
$1K |
| J1940 |
Injection, furosemide, up to 20 mg |
1,022 |
661 |
$1K |
| 86923 |
|
220 |
173 |
$1K |
| 99153 |
Mod sedat endo service >5yrs |
85 |
70 |
$1K |
| 82274 |
|
980 |
934 |
$1K |
| 85651 |
|
1,909 |
1,801 |
$1K |
| 36600 |
|
167 |
161 |
$1K |
| 90686 |
|
175 |
172 |
$1K |
| 94726 |
|
16 |
16 |
$1K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
811 |
548 |
$1K |
| 86756 |
|
804 |
797 |
$1K |
| J0290 |
Injection, ampicillin sodium, 500 mg |
510 |
502 |
$1K |
| 86480 |
|
29 |
29 |
$991.60 |
| 83970 |
|
123 |
116 |
$989.55 |
| OP255 |
|
1,648 |
1,504 |
$970.66 |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
56 |
49 |
$864.45 |
| 80074 |
|
76 |
71 |
$857.98 |
| 88173 |
|
25 |
24 |
$816.00 |
| 73523 |
|
13 |
13 |
$807.58 |
| 97535 |
Self-care/home management training, each 15 minutes |
241 |
174 |
$801.61 |
| OP271 |
|
105 |
98 |
$766.75 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
320 |
211 |
$754.13 |
| A9558 |
Xenon xe-133 gas, diagnostic, per 10 millicuries |
78 |
78 |
$744.55 |
| 90675 |
|
34 |
16 |
$739.52 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
571 |
353 |
$720.67 |
| 80305 |
|
55 |
24 |
$666.48 |
| J3480 |
Injection, potassium chloride, per 2 meq |
509 |
357 |
$656.84 |
| 82150 |
|
280 |
276 |
$629.65 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
76 |
74 |
$615.52 |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
403 |
271 |
$596.44 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
367 |
191 |
$580.88 |
| 29505 |
|
40 |
40 |
$545.26 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
782 |
583 |
$532.52 |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
27 |
27 |
$527.72 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
134 |
96 |
$500.88 |
| 76937 |
|
80 |
63 |
$478.41 |
| 82378 |
|
31 |
24 |
$461.09 |
| 86708 |
|
39 |
39 |
$456.00 |
| 82570 |
|
695 |
627 |
$448.59 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
46 |
39 |
$433.49 |
| J3411 |
Injection, thiamine hcl, 100 mg |
251 |
161 |
$425.40 |
| 85576 |
|
12 |
12 |
$408.12 |
| 86704 |
|
29 |
29 |
$405.00 |
| 0031A |
|
19 |
19 |
$398.73 |
| 86780 |
|
124 |
120 |
$368.61 |
| 82043 |
|
368 |
365 |
$363.06 |
| 86592 |
|
1,323 |
1,313 |
$343.71 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
459 |
399 |
$340.59 |
| 12013 |
|
16 |
14 |
$323.18 |
| Q0247 |
Injection, sotrovimab, 500 mg |
55 |
48 |
$307.95 |
| J2305 |
Injection, nitroglycerin, 5 mg |
98 |
92 |
$302.79 |
| 29130 |
|
57 |
52 |
$285.65 |
| 96368 |
|
19 |
13 |
$284.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
443 |
376 |
$275.69 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
99 |
66 |
$273.38 |
| 83550 |
|
40 |
40 |
$273.06 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
13 |
12 |
$249.34 |
| J1790 |
Injection, droperidol, up to 5 mg |
222 |
198 |
$247.78 |
| 85347 |
|
155 |
134 |
$242.74 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
557 |
500 |
$233.32 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
246 |
213 |
$232.55 |
| 97165 |
|
24 |
24 |
$199.74 |
| J0703 |
Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg |
94 |
44 |
$190.91 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
462 |
339 |
$180.14 |
| 84481 |
|
26 |
25 |
$165.50 |
| 82803 |
|
40 |
38 |
$165.00 |
| 87493 |
|
24 |
24 |
$163.01 |
| 97166 |
|
34 |
31 |
$154.02 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
18 |
13 |
$144.45 |
| 82947 |
|
808 |
746 |
$129.19 |
| 73660 |
|
30 |
28 |
$129.09 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
509 |
393 |
$104.33 |
| 85384 |
|
24 |
24 |
$96.00 |
| 94660 |
|
16 |
12 |
$85.50 |
| 82950 |
|
26 |
26 |
$78.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
114 |
90 |
$74.57 |
| 82108 |
|
16 |
16 |
$73.74 |
| 86308 |
|
119 |
117 |
$68.02 |
| 84295 |
|
605 |
557 |
$50.60 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
471 |
423 |
$48.92 |
| 83930 |
|
65 |
60 |
$47.61 |
| 82310 |
|
122 |
101 |
$44.98 |
| 80202 |
|
40 |
28 |
$43.32 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
89 |
71 |
$42.99 |
| 87045 |
|
25 |
24 |
$40.65 |
| 82435 |
|
543 |
494 |
$34.85 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
140 |
106 |
$32.70 |
| 90656 |
|
19 |
18 |
$32.10 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
24 |
24 |
$31.44 |
| 82140 |
|
51 |
40 |
$31.13 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
47 |
30 |
$30.91 |
| J0572 |
Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine |
15 |
12 |
$26.49 |
| J1836 |
Injection, metronidazole, 10 mg |
20 |
13 |
$22.44 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
86 |
75 |
$19.42 |
| 84520 |
|
154 |
128 |
$16.50 |
| J3360 |
Injection, diazepam, up to 5 mg |
42 |
39 |
$8.32 |
| J0456 |
Injection, azithromycin, 500 mg |
24 |
12 |
$7.93 |
| 88300 |
|
18 |
14 |
$7.23 |
| 88302 |
|
14 |
12 |
$5.34 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
88 |
84 |
$5.00 |
| 84300 |
|
17 |
14 |
$4.05 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
301 |
210 |
$3.37 |
| J7070 |
Infusion, d5w, 1000 cc |
12 |
12 |
$3.32 |
| 90585 |
|
20 |
15 |
$3.00 |
| 91303 |
|
18 |
18 |
$1.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
783 |
744 |
$0.01 |
| G0237 |
Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring) |
23 |
13 |
$0.00 |
| OP911 |
|
31 |
26 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13 |
12 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
202 |
152 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
100 |
75 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
857 |
827 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
12 |
12 |
$0.00 |